Frank Gupton, CEO of Medicines for All, said he hopes that will lead to production facilities closer to those high need areas like sub-Saharan Africa.
Zimbabwe clears key hurdle for energy project Zimbabwe’s energy sector has reached a major milestone following the successful ...
Coalition of charities and MPs have signed a letter from Geordie Greig, editor-in-chief of The Independent, appealing to the ...
Pharmaceutical Technology on MSN

UK approves Gilead’s twice-yearly HIV PrEP drug

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...
A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.
Some local officials want to hamper needle exchange programs that public health officials say are crucial to reducing the spread of blood-borne diseases.